Scribe Therapeutics Inc. (SCTX)

Scribe Therapeutics will go public soon, but the exact IPO date is still unknown.

Stock Price: Pending

IPO price not available yet

Scribe Therapeutics Statistics

Total Valuation

Market Cap	n/a
Enterprise Value	n/a

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	0.64
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	97.08

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	n/a
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	$407,663
Profits Per Employee	-$401,461
Employee Count	89
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-1.26M
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	n/a
200-Day Moving Average	n/a
Relative Strength Index (RSI)	n/a
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, SCTX had revenue of $36.28 million and -$35.73 million in losses.

Revenue	36.28M
Gross Profit	36.28M
Operating Income	-32.94M
Pretax Income	-36.99M
Net Income	-35.73M
EBITDA	-33.50M
EBIT	-37.37M
Earnings Per Share (EPS)	n/a

Full Income Statement

Balance Sheet

The company has $49.73 million in cash and $46.33 million in debt, with a net cash position of $3.40 million.

Cash & Cash Equivalents	49.73M
Total Debt	46.33M
Net Cash	3.40M
Net Cash Per Share	n/a
Equity (Book Value)	-158.74M
Book Value Per Share	n/a
Working Capital	-27.32M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$39.15 million and capital expenditures -$797,000, giving a free cash flow of -$39.94 million.

Operating Cash Flow	-39.15M
Capital Expenditures	-797,000
Depreciation & Amortization	3.87M
Net Borrowing	n/a
Free Cash Flow	-39.94M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of -90.79% and -98.48%.

Gross Margin	100.00%
Operating Margin	-90.79%
Pretax Margin	-101.95%
Profit Margin	-98.48%
EBITDA Margin	-92.34%
EBIT Margin	-103.01%
FCF Margin	-110.09%

Dividends & Yields

SCTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	n/a
FCF Yield	n/a

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (3Y)	n/a
EPS Growth Forecast (3Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a